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T. Kudo,* Y. Inoue, H. Nakamura, N. Sugano, M. Hirokawa and T. IwaiDepartment of Vascular and Applied Surgery, Graduate School, Tokyo Medical and Dental University,
Tokyo, JapanObjective. To evaluate the characteristics of distal microembolic signals (MES) during iliac stenting using Doppler
ultrasound monitoring.
Design. Prospective clinical study.
Methods. A 2-MHz probe was used to monitor continuously at the ipsilateral tibioperoneal trunks during technically and
hemodynamically successful iliac stenting in 10 patients without infrainguinal occlusive lesion. MESs at guide-wire,
balloon, or stent crossing (phase 1), predilatation (phase 2), stent deployment (phase 3), postdilatation (phase 4), and
contrast medium or heparinized saline injection (at injection) were analyzed. Differentiation of gaseous emboli from
particulate emboli was achieved by calculation of the sample volume length.
Results. No distal embolic complications were observed. Five hundred and forty-one MESs were detected. The MES
incidence and intensity in phase 3 were significantly higher than those in phase 1, phase 2, and phase 4 (p!0.05). The MES
intensity at injection was significantly higher than that in each of four phases (p!0.0001).
Conclusions. Both the MES incidence and intensity were highest at stent deployment. Further study is required of
microembolism during endovascular procedures in the lower extremities.Keywords: Microembolization; Iliac artery; Stent; Angioplasty; Doppler ultrasound.Introduction
Embolization to the distal arteries can complicate
percutaneous transluminal angioplasty (PTA) and
stent placement for the treatment of stenotic periph-
eral arterial lesions.1,2 However, there have been few
reports regarding microembolic detection using Dop-
pler ultrasound in the peripheral arteries.3–6 Further-
more, to our knowledge, no documentation has been
reported regarding profiles of distal microemboli (ME)
during endovascular procedures in the peripheral
circulation.
The purpose of this study is to evaluate the
characteristics of distal ME during stent placement in
patients with iliac occlusive disease using Doppler
ultrasound monitoring.ng author. Dr Toshifumi Kudo, MD, PhD, Department
nd Applied Surgery, Graduate School, Tokyo Medical
niversity, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8519,
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Ten patients (eight men and two women) with the
mean age of 67 (range 56–81) were included in this
study. Indication for iliac stenting was intermittent
claudication in nine patients and an ischemic foot
ulcer in one. The preoperative median ankle brachial
pressure index (ABI) was 0.60 (range 0.45–0.85). Each
patient had a solitary iliac stenotic lesion (seven
common iliac arteries [CIA] and three external iliac
arteries) with the median degree of 70% (range 65–
99%) and the median length of 20 mm (range 8–
37 mm). Angiography revealed no significant occlu-
sive lesion in the ipsilateral infrainguinal vascular
trees. In seven patients with CIA lesions, five had
occluded ipsilateral internal iliac arteries (IIA) and two
had high-grade stenosis at the IIA orifice. All patients
were treated with antiplatelet drugs including aspirin
and cilostazol, which were ceased 5 days before the
procedure, resumed after the procedure and contin-
ued thereafter. Patients, who had cardiac arrhythmiaEur J Vasc Endovasc Surg 30, 311–314 (2005)
doi:10.1016/j.ejvs.2005.04.004, available online at http://www.sciencedirect.com oned.
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therapy, were excluded from this study. All patients
gave signed informed consent.Stent placement
Iliac stent placement with pre- and post-dilatation was
performed via the ipsilateral common femoral artery
(CFA) route under local anesthesia. A 5-Fr sheath was
placed in the CFA through which a 5-Fr catheter
was passed into the abdominal aorta. Angiography
was performed to confirm the degree and the length of
stenosis and the luminal diameter of the artery
immediately proximal to the lesion. A balloon
(Synergyw, Boston Scientific Co., Natick, MA, USA)
1-mm larger in diameter was selected, and the length
of the balloon was determined to just exceed the length
of the lesion. A self-expandable stent (Easy Wallstentw,
Boston Scientific Co., Natick, MA, USA) was used in
all patients. The diameter of the stent was the same
size as the balloon. The balloon was dilated for 30 s at
pre- and post-dilatation. Pressure was 4 to 8 atmos-
pheres. The contrast medium used was iohexol
(Omnipaquew, Nylomed, Birmingham, UK), a non-
ionic contrast medium with concentration of 300 mg
iodine per milli liter. An intra-arterial bolus dose of
50 IU/kg of heparin was administered before the
procedure, and the completion angiography was
performed immediately after the procedure. The
femoral arterial sheath was removed with com-
pression of the puncture site.Doppler ultrasound monitoring
In the current study, a commercially available Doppler
ultrasound machine (EME Companion, Nicolet Bio-
medical, Madison, WI, USA) was used with a 2-MHz
transducer. A single operator performed monitoring in
all patients. The settings of the Doppler apparatus
were determined as follows:5 the intensity threshold
was 3 dB; a 128-point fast Fourier transform with a
time-window overlap of 67% was used; scale setting
was K50 to 100 cm/s; a high-pass filter was set at
106 Hz; the sample volume was 10 mm; the amplitude
was 44% (the minimum); and the gain was reduced to
2–6. The probe was fixed with specially designed
holder at the anteromedial aspect of the calf and
adjusted to an insonation angle of 608 to detect the
tibioperoneal trunk. Depth was determined to obtain
optimal Doppler flow wave of the artery (median
42 mm; range 38–48 mm). The recording was made
continuously from the placement of the sheath at theEur J Vasc Endovasc Surg Vol 30, September 2005CFA to the completion of stent placement and the
removal of the sheath.Data analysis
All Doppler audio signals were recorded onto hard
disc of the same Doppler ultrasound machine for off-
line analysis. The SoundTrak software and a fine
resolution mode were supplied with this machine
(Nicolet Biomedical, Madison, WI, USA). The follow-
ing identification criteria as microembolic signals
(MES) was used for off-line analysis: intensity increase
3 dB above background, short duration (!300 ms),
unidirectional, random appearance in the cardiac
cycle, and with characteristic sound on the audible
output according to a recent consensus.7Statistical analysis
Continuous variables were described as median and
range. Statistics for between-group differences were
calculated with the Mann–Whitney U-test (M–W).
Variables were considered significant if the p value
was less than 0.05.Results
In all patients, the stent placement was technically and
hemodynamically successful defined by following
criteria: completion angiography demonstrating less
than 30% residual stenosis; the ABI was ameliorated
more than 0.1; and the symptoms improved. No
patient showed distal embolic complications after the
procedure. Balloons’ sizes used ranged from 6 to
10 mm in diameter and from 1.8 to 4 cm in length, and
stents’ sizes from 7 to 10 mm in diameter and from 2.7
to 6 cm in length. Predilatation was performed once in
eight patients, twice in three, and three times in one,
while two had no predilatation. One stent was placed
in each patient. Postdilatation was performed once in
two patients, twice in five, three times in two, four
times in one. Doppler ultrasound monitoring was
possible, and the study protocol was completed in all
subjects.
A total of 541 MES were detected: 56 at passage of
guide-wire, balloon, and stent (phase 1), 59 immedi-
ately after predilatation with balloon (phase 2), 119
during and immediately after stent deployment
(phase 3), 44 immediately after postdilatation with
balloon (phase 4), and 263 at injection of contrast
medium or heparinized saline (at injection). In phase 1,
the median incidence (range) and intensity (range) of
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25 dB (7–35 dB) at guide-wire crossing (nZ17), 2 (1–
12) and 28 dB (13–39 dB) at balloon passage for
predilatation (nZ27), 0 (0–3) and 27.5 dB (7–34 dB) at
stent passage (nZ8), and 0 (0–2) and 21 dB (15–32 dB)
at balloon passage for postdilatation (nZ4).
The sample volume length (Zemboli velocity!
duration; SVL)3,8 of each MES in phase 1, phase 2, and
phase 4, was calculated with the finest resolution
mode. The SVLs of 159 MESs were analyzed and they
had a median of 0.63 cm ranging from 0.12 to 1.31 cm.
Based on this observation, the SVL threshold for
determining embolic composition was assumed at
1.32 cm, with emboli producing SVLs less than 1.32 cm
being classified as particulate and all those with SVLs
greater than 1.32 cm, being classified as gaseous.
According to this criterion, 100 (84.0%) MESs in phase
3 were defined as particulate, and 249 (94.7%) MESs at
injection as gaseous. MESs with SVLs more than 1.32 cm
in phase 3 and less than 1.32 cm at injection was
excluded from the following statistical analysis.
In analysis of the MES incidence, MESs at the
second or further balloon dilatation in phase 2 (nZ11)
and phase 4 (nZ15) were excluded. The MES
incidence in phase 3 (median 9, range 4–18) was
significantly higher than that in phase 1 (median 3.5,
range 1–15) (M–W, pZ0.048), phase 2 (median 3.5,
range 1–21) (M–W, pZ0.037), and in phase 4 (median
1.5, range 1–9) (M–W, pZ0.0017) (Fig. 1). There was no
significant difference of the MES incidence between
phase 1 and phase 2 (M–W, pZ0.89), phase 1 and
phase 4 (M–W, pZ0.14), and phase 2 and phase 4 (M–
W, pZ0.12). In phase 1, the MES incidence atFig. 1. The incidence of MES is plotted in each phase. MES at
the second or further balloon dilatation are excluded in
phase 2 and phase 4, if performed. The MES incidence in
phase 3 was significantly higher than that in phase 1, phase 2
and, phase 3. *p!0.05, **p!0.01. MES, microembolic signals;
phase 1, at guide-wire, balloon, or stent crossing; phase 2,
immediately after predilatation with balloon; phase 3,
during and after stent deployment; phase 4, immediately
after postdilatation with balloon.postdilatation balloon passage was significantly
lower than that at guide-wire crossing (M–W, pZ
0.041) and predilatation balloon passage (M–W, pZ
0.0045).
The MES intensity in phase 3 (median 29 dB, range
9–43 dB) was significantly higher than that in phase 1
(median 26.5 dB, range, 7–37 dB) (M–W, pZ0.033),
phase 2 (median 24 dB, range 7–43 dB) (M–W, pZ
0.0027), and phase 4 (median 19 dB, range 8–40 dB)
(M–W, p!0.0001) (Fig. 2). The MES intensity in phase
1 was significantly higher than that in phase 4 (M–W,
pZ0.0082). The MES intensity at injection (median
33 dB, range 10–45 dB) was significantly higher than
that in each of four phases (M–W, p!0.0001). There
was no significant difference of the MES intensity
between phase 1 and phase 2 (M–W, pZ0.28), and
phase 2 and phase 4 (M–W, pZ0.21). In phase 1, the
MES intensity at predilatation balloon passage was
significantly higher than that at guide-wire crossing
(M–W, pZ0.049).Discussion
In the current study, it was considered that endovas-
cular procedures in each phase were associated with
multiple embolic particles generated from plaques as
described in the previous reports.9–12 Our result
agreed with one previous report which documented
that self-expandable stent deployment was associated
with higher embolic risk than pre- and post-dilata-
tion.11 The author described that it was possible thatFig. 2. The intensity of MESs is plotted. The MES intensity in
phase 2 was significantly higher than that in phase 1, phase 2,
and phase 3. Phase 1 had significantly higher MES intensity
compared with phase 4. The intensity of MESs at hepar-
inized saline or contrast medium injection (at injection) is
significantly higher than that in phase 1, phase 2, phase 3,
and phase 4. *p!0.05, **p!0.01, ***p!0.001. MES, micro-
embolic signals; phase 1, at guide-wire, balloon, or stent
crossing; phase 2, immediately after predilatation with
balloon; phase 3, during and after stent deployment; phase
4, immediately after postdilatation with balloon.
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usually oversized to the artery, were responsible for
the increased embolic release. In addition, mechanical
factors, as trauma on the plaque surface with sharp
end and hard material of stents compared with balloon
surface, might act to dislodge higher number and
larger size of emboli during their deployment. On the
other hand, two previous documentations reported
that carotid stent deployment was associated with low
embolic risk due to the scaffolding effect of the stent,
which traps atherosclerotic debris against the arterial
wall.9,10 However, a major difference should be
considered between the carotid procedures and the
iliac procedures. Manninen et al.12 suggested that a
self-expandable stent had the ability to expand during
placement, beginning from the distal end and trapping
the embolic fragments in place in the carotid artery. In
contrast, such entrapment function might not be
available in the current study because stent placement
was approached from the ipsilateral femoral artery
and stent deployment began from the proximal end in
all cases. Self-expandable stent placement with a
retrograde approach might contribute to higher
potential embolic risk.
Orlandi et al.10 reported no substantial difference of
the MES intensity between angioplasty group and
stenting group in their series of carotid stenosis. The
author described that the MES intensity seemed to
have no clear significance since it might depend both
on the volume and on the nature of ME. However,
Manninen et al.12 investigated the histological nature
of ME in an experimental model and reported that
there was no difference between PTA alone group and
stenting group. Thus, although the histological nature
of ME in four phases (guide-wire, balloon, and stent
manipulation, predilatation, stent deployment, and
postdilatation) was not assessed in the current study,
the MES intensity could represent the volume of ME
rather than the nature of ME during endovascular
procedures. A higher intensity of MES could represent
a larger size of ME.5,13
The higher MES intensity as measured by dB in
phase 3 may reflect gaseous embolization from within
the self-expandable stent even though we character-
ized emboli using the criterion with SVL.3,8 However,
to our knowledge, there is no ‘gold standard’ for
discrimination between gaseous and solid emboli.
Even human experts, currently considered as the ‘gold
standard’ for embolus detection, cannot reliably
decide on the gaseous or solid nature of Doppler
signals.14
Our results using the Doppler MES profile duringEur J Vasc Endovasc Surg Vol 30, September 2005stenting in the iliac artery demonstrate four critical
phases responsible for increased MESs, with the
highest incidence and intensity of MESs observed at
stent deployment. Further investigation of microem-
bolization during endovascular procedures in the
peripheral circulation is indicated.References
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